Michael Heathman, M.S.

Group Leader, Senior Principal Scientist I

Michael brings over 30 years of experience in the pharmaceutical industry.  Prior to joining Metrum Research Group in 2018, he was Head of Global Pharmacometrics at Eli Lilly and Company, where he led efforts to apply PK/PD modeling and simulation to all phases of drug development.  He has extensive experience in the application of pharmacometrics to support quantitative decision making across a broad range of disease states and therapeutic areas.

Recent publications by this scientist

Pharmacokinetic modeling of R and S-Methadone and their metabolites to study the effects of various covariates in post-operative children

August 26, 2021

Aruldhas, B. W., Quinney, S. K., Overholser, B. R., Heathman, M. A., Masters, A. R., Ly, R. C., Gao, H., Packiasabapathy, S., & Sadhasivam, S. CPT Pharmacometrics Syst Pharmacol2021001– 12https://doi.org/10.1002/psp4.12687

View More

Postprandial triglyceride reduction following acute treatment of a selective 5-hydroxytryptamine-2c agonist and characterization using a semi-physiological model.

April 23, 2021

Leohr J, Heathman M, Kjellsson MC. Diabetes Obes Metab. 2021 Apr;23(4):1001-1010. doi: 10.1111/dom.14306.

View More